Navigation Links
Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results,of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Company's,Investigational Drug to Treat Cocaine and Methamphetamine Addiction

atening condition for which there is no effective treatment and which demonstrates the potential to address unmet medical needs. For more information about the Company, go to www.catalystpharma.com.

This press release contains forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties which may cause the Company's actual results in future periods to differ materially from forecasted results. A number of factors, including that the final results of our bioequivalence study will be consistent with the top-line results received to date and those described in the Annual Report on Form 10-K that the Company has filed with the U.S. Securities and Exchange Commission ("SEC") reporting its financial position and results of operations as of and for the year ended December 31, 2006, could adversely affect the Company's ability to obtain these results. Copies of the Company's filings with the SEC are available from the SEC or may be obtained upon request from the Company. The Company does not undertake any obligation to update the information contained herein, which speaks only as of this date.

CONTACT: Patrick J. McEnany, Chief Executive Officer, +1-305-529-2522,, or Jack Weinstein, Chief Financial Officer,+1-201-934-4201, , both of CatalystPharmaceutical Partners; media, Tina Posterli, Rx Communications Group,+1-917-322-2565, pmcenany@catalystpharma.com jweinstein@catalystpharma.com tposterli@rxir.com

Web site: http://www.catalystpharma.com//

Ticker Symbol: (NASDAQ-NMS:CPRX)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All ri
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Materia Licenses Metathesis Catalyst Platform to Eisai
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
Post Your Comments:
(Date:6/19/2013)... June 19, 2013   NextDocs announced today ... clinical research organization, at DIA 2013 , the ... will present case studies that explore best practices for ... electronic trial master file (eTMF) systems. ... present alongside Krystyna Kowalczyk , executive vice president ...
(Date:6/19/2013)... 2013  Caradigm today announced the availability ... to help healthcare organizations efficiently manage clinician ... their compliance with data privacy regulations. The ... in the delivery of advanced role lifecycle ... systems. (Photo: http://photos.prnewswire.com/prnh/20130619/SF34463LOGO ...
(Date:6/19/2013)... YORK , June 19, 2013   Voices ... to finding a cure for brain cancer, today announced ... a grant to support the clinical investigation of Toca ... recurrent high grade glioma brain cancer (Grade 3 or ... developing novel treatments for advanced cancer, with an initial ...
Breaking Medicine Technology:NextDocs and Novella to Present on eTMF at DIA 2013 2Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 2Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 3Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3
... and Methods, ROCKVILLE, Md., June 11 ... company developing,therapeutics for the treatment of cancer and ... No. 7,371,741 covering analogs of 2-,methoxyestradiol (2ME2). The ... property protection through 2025 for analogs,of 2ME2 in ...
... 11 , - Data Published in the ... no Negative Impact on Overall Survival or Tumour,Progression, ... randomised, controlled,studies in 2,301 cancer patients shows that ... impact on survival, tumour,progression or deaths caused by ...
Cached Medicine Technology:EntreMed Receives New Patent for 2-Methoxyestradiol Analogs 2EntreMed Receives New Patent for 2-Methoxyestradiol Analogs 3New Meta-Analysis Confirms Safety Profile for NeoRecormon in Treating Anaemia in Cancer Patients 2
(Date:6/20/2013)... natural health and wellness coach Carol cited ... revealed that performing random acts of kindness – whether ... the feel-good hormone Oxytocin in the brain and throughout ... protective’ hormone because it temporarily lowers blood pressure which ... kind is something we can all do, doesn’t cost ...
(Date:6/20/2013)... Lake City, UT (PRWEB) June 20, 2013 ... #1 assurance solution that guides users through a HIPAA ... The new website launched today extends the reach ... audience of HIPAA Security Officers, HIPAA Privacy Officers, security ... compliance, security, privacy, consulting, measures, processes, policies and procedures. ...
(Date:6/19/2013)... Santiago, Chile (PRWEB) June 20, 2013 ... Chile Montaña has put together their winter season ... of outdoor adventure day trips in and around Santiago ... lead trips into Chile's Central Andes for backcountry skiing, ... , For those who have always dreamed of ...
(Date:6/19/2013)... 2013 Brand new Hypertrophy Max bonus just released ... sale on the Hypertrophy Max program. Vince and Ben are ... those that are interested must act quickly. , What is the ... bonus is a free 12 month all access pass to the ... Ryan Davids "Live Large TV is a Monday night show where ...
(Date:6/19/2013)... Florida (PRWEB) June 19, 2013 Go Classy ... Clothing Optional Resorts for over 25 Years. These ... nude beaches, nude pools, nude bars and nude hot tubs. ... lifestyle clients alike. When SuperClubs re-branded the resort to ... of the nude side of the Resort fell off dramatically. ...
Breaking Medicine News(10 mins):Health News:Kindness Can Be Good for The Heart Says BioGirl Health Show 2Health News:Kindness Can Be Good for The Heart Says BioGirl Health Show 3Health News:Modern Compliance Solutions Launches a New Web Site Promoting the Industry-Proven, Web-Based HIPAA One Security Solution 2Health News:Chile Montaña Announces Winter Season Santiago Day Trips 2Health News:Chile Montaña Announces Winter Season Santiago Day Trips 3Health News:New Hypertrophy Max Bonus Just Released and Only Available for 24 Hours 2Health News:The Former Breezes Resort is Re-Opened by Blue Diamond Resorts as the Original Grand Lido Negril Announced Go Classy Tours 2
... U.S. News & World Report has ranked,Cincinnati Children,s ... United States in general pediatrics in the 2008 edition ... is,the highest Cincinnati Children,s has ever received from U.S. ... we owe a great debt of thanks,to the thousands ...
... WASHINGTON, May 30 The National Alliance on,Mental ... for her,contributions to public education about mental illness ... 2008., NAMI executive director Mike Fitzpatrick made ... in which he discussed the premiere of,two ...
... May 30 The following is being issued,by the Federation ... physician scientists from 58 countries across the globe, What: ... When: Wednesday, June 4-Monday, June 9, Where: Boston Marriott ... accelerate science that improves patient care, Wednesday, June 4, ...
... is Dec. 31, but FDA urges asthma patients to ... (HealthDay News) -- Asthma inhalers that contain the drug ... harm the ozone layer. And these inhalers won,t be ... urging patients to switch to alternative inhalers now. , ...
... hardest hit ... areas of the country, WILMINGTON, ... homeless after Cyclone Nargis swept through Myanmar. Malteser,International has been providing ... of Labutta in the Irrawaddy Delta. Present in,Myanmar since 2001, Malteser ...
... Indiana experienced a 50 percent membership ... growth since 2007, ... this 14-year-old, not-for-profit,Indiana managed health care plan -- surpassing the 300,000 mark ... 2007, the,company has also grown its employee base by 182 percent -- ...
Cached Medicine News:Health News:U.S. News Ranks Cincinnati Children's Among Top Three U.S. Children's Hospitals 2Health News:U.S. News Ranks Cincinnati Children's Among Top Three U.S. Children's Hospitals 3Health News:NAMI Blog: PBS, MTV and Jane Pauley 2Health News:World-Renowned Scientists to Lead Immunology Course 2Health News:World-Renowned Scientists to Lead Immunology Course 3Health News:World-Renowned Scientists to Lead Immunology Course 4Health News:Ozone-Depleting Inhalers Being Phased Out 2Health News:Ozone-Depleting Inhalers Being Phased Out 3Health News:More Than 78,000 are Dead and Millions are Homeless After Cyclone Nargis Swept Through Myanmar 2Health News:MDwise Enrollment Exceeds 300,000 Members 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: